TomoTherapy reports 86% revenue jump, $131M net loss in Q1
In its first financial report since becoming a publicly traded company, Madison's TomoTherapy reported surging revenues and a hefty net loss that was due in part to a temporary accounting adjustment. The report does not include $186 million in net proceeds from its recent IPO,...